Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chlamydia Therapy
Treatment failures for Chlamydia trachomatis evaluated
May 5th, 2005
Scientists have evaluated antimicrobial resistance and treatment failures for Chlamydia trachomatis. According to a study from the United States and Switzerland, "Each year, Chlamydia trachomatis causes {{approx}}3 million new infections and results in more than $1 billion in medical costs in the United States. Repeat or persistent infection occurs in 10% to 15% of women who are treated for C. trachomatis infection. However, the role played by antimicrobial resistance in C. trachomatis treatment failures or persistent infection is unclear. With researchers in the field, we reviewed current knowledge and available approaches for evaluating...
Source: Women's Health Weekly (2005-05-05)
|
